Abstract：【Objective】To investigate the effects of hemodialysis with different fluxes on cardiac function, myocardial enzymes and prognosis in elderly patients with diabetic nephropathy (DN). 【Methods】 The clinical data of 88 elderly patients with DN admitted to the hospital were retrospectively analyzed. There were 46 patients treated with high-throughput hemodialysis in group A and in the same period 42 patients were treated with low-throughput hemodialysis in group B. Cardiac function indicators: left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter (LVEDD), interventricular septal diastolic thickness (IVSDT), Myocardial enzyme indicators such as creatine phosphokinase (CK), lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBDH) and blood pressure were compared before and after treatment in two groups. The incidence of cardiovascular events in the 12 months of follow-up were statistically analyzed. The survival at 6 months and 12 months during the follow-up period were counted. 【Results】There was no significant difference in each indicator between the two groups before treatment (P>0.05). LVEF level was increased after treatment in both groups (P<0.05), and LVEF level in group A was significantly higher than that in group B (P<0.05). After treatment, LVEDD and IVSDT in both groups were reduced (P<0.05), and levels of LVEDD and IVSDT in group A were significantly lower than those in group B (P<0.05). CK, LDH and HBDH levels in the two groups were all decreased after treatment (P<0.05), while levels of CK, LDH and HBDH in group A were significantly lower than those in group B (P<0.05). There was no significant difference in systolic and diastolic blood pressure between the two groups before and after treatment (P>0.05). The total incidence rate of cardiovascular events in group A was lower than that in group B (P<0.05). There was no significant difference in 6-month survival rate between the two groups(P>0.05), while the 12-month survival rate in group A was higher than that in group B (P<0.05). 【Conclusion】High-throughput hemodialysis for elderly patients with DN can effectively improve their cardiac function, reduce the level of myocardial enzymes and the incidence of cardiovascular events, and improve the survival rate.
常露元, 赵辽辽. 不同通量的血液透析治疗对老年糖尿病肾病患者心功能、心肌酶及预后的影响[J]. 医学临床研究, 2022, 39(3): 425-428.
CHANG Lu-yuan, ZHAO Liao-liao. Effect of Hemodialysis with Different Fluxes on Cardiac Function, Myocardial Enzymes and prognosis in Elderly Patients with Diabetic Nephropathy. JOURNAL OF CLINICAL RESEARCH, 2022, 39(3): 425-428.
[1] 周麟,李毅. 糖尿病肾病患者并发心血管病的影响因素分析[J].医学临床研究,2018,35(8):1593-1595. [2] CASTILLO-TORRES S A,IBARRA-SIFUENTES HR,SNCHEZ-TERN H,et al. Restless legs syndrome in end-stage renal disease patients undergoing hemodialysis[J].Arquivos de Neuro-Psiquiatria,2018,76(12):827-830. [3] 邵宏宾.连续性肾脏替代与间竭性血液透析治疗重症急性肾衰竭的效果对比[J].中国社区医院,2018,32(5):471-475. [4] 裴剑浩. 中国糖尿病诊疗指南解读--糖尿病肾病[J].中国医师杂志,2014,16(2):161-163. [5] 任晓梅,杨景锋,刘启玲,等. 基于基因组学探讨糖尿病肾病的发病原因及其与心血管疾病的关系[J].西安交通大学学报,2018,39(2):266-270. [6] BADAWY A,NIGM D,FARGHALY H,et al. Effect of high flux versus low flux hemodialysis on some cardiovascular risk factors in egyptian children with end stage renal disease[J].Int J Mol Sci,2019,14(1):15-23. [7] 余丽娟. 两种血液透析方式在维持性血液透析患者中的应用效果比较[J].中华现代护理杂志,2020,26(16):2219-2222. [8] 翟英,李向东,李毅,等. 高通量透析对糖尿病肾脏疾病患者糖基化终产物及微炎症的影响[J].临床肾脏病杂志,2018,18(7):409-412. [9] HAN S,YANG K,ZHU H,et al. Proteomics investigation of the changes in serum proteins after high-and low-flux hemodialysis[J].Renal Failure,2018,40(1):506-513. [10] 王松岩,张世英,王磊,等. 高通量血液透析患者心脏结构和功能的影响因素分析[J].中国实验诊断学,2018,22(3):488-490.
2022, Vol. 39 
